GlobalData research has found the top biosimilar influencers based on their performance and engagement online. Using research from GlobalData’s Influencer platform, Pharmaceutical Technology has named ten of the most influential people and organisations in biosimilars on Twitter during Q2 2020.
Biggest biosimilar influencers: The top ten in Q2 2020
1. RAPS (@RAPSorg)
The Regulatory Affairs Professionals Society (RAPS) is a non-profit organisation providing training, research, and other tools to people involved in the regulation of healthcare and related products.
Founded in 1976, the association provides support for the regulation of products such as medical devices, pharmaceuticals, and nutritional products. The organisation helps in ensuring good regulatory practices and policies for public health.
Twitter followers: 10,169
GlobalData influencer score: 100
— Regulatory Affairs Professionals Society (@RAPSorg) June 29, 2020
2. Biosimilars101 (@biosimilars101)
Biosimilars101 provides news and information about the safety and use of biosimilars, or FDA-approved biologic medicines for patients and physicians alike. The posts shared on the influencer’s Facebook page range from studies and articles supporting the use of biosimilars and articles busting the myths surrounding biosimilars.
Twitter followers: 7,169
GlobalData influencer score: 96
A recent study published by @AmDiabetesAssn found that England saved $1.1 million by using insulin #biosimilars from 2014 – 2018, but could have saved more than $30 million more if there was broader uptake https://t.co/T78OipXs2c
— biosimilars101 (@biosimilars101) June 23, 2020
3. Biosimilars Council (@BiosimsCouncil)
The Biosimilars Council is an organisation that seeks to create a positive environment for affordable access to biosimilar medicines for all consumers. The council is a part of the Association for Accessible Medicines (formerly Generic Pharmaceutical Association or GPhA), a trade association representing manufacturers of generic pharmaceutical products.
The organisation educates the public about the legal affairs, regulatory environment, and access to biosimilar medicines. Members of the council include companies and stakeholders developing biosimilar medicines.
Twitter followers: 9,541
GlobalData influencer score: 70
Educating stakeholders & ensuring access to treatment should continue during COVID-19. To keep up education of #biosimilars & the 10 year anniversary of #BPCIA, we sought an innovative way to spread our message using an @Instagram filter https://t.co/KoJUa7bm4R @prsa #b10similars pic.twitter.com/vQIVgy5rSR
— Biosimilars Council (@BiosimsCouncil) April 15, 2020
4. Biosimilars Forum (@USBiosimilars)
Biosimilars Forum is an association that works towards the increased adoption of biosimilars in the US. As a non-profit organisation, the association focuses on improving healthcare as well as expanding the access and availability of biological medicines. It also provides information to support public policies that advocate the use and adoption of biosimilars.
Twitter followers: 8,025
GlobalData influencer score: 68
☑️ Reduce a patient’s average out-of-pocket costs by 17 percent
☑️ Reduce total out-of-pocket spending by $238 million
Learn more: https://t.co/7MF0MuG4Zh
— Biosimilars Forum (@USBiosimilars) June 16, 2020
5. EFPIA (@EFPIA)
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents Europe’s pharmaceutical industry. Its members comprise pharmaceutical companies, national associations, and small and medium-sized enterprises, who research, develop, and deliver new medicines, vaccines and therapies to Europe and across the world.
Twitter followers: 23,361
GlobalData influencer score: 65
Europe's regulatory framework has helped extend millions of lives. Since 1995, @EMA_News has authorized over 1400 medicines. Here’s our #RegulatoryRoadToInnovation, to deliver safer, better medicines to patients, faster#KeepTheSparkAlive #DIAEurope2020 https://t.co/lvPbt49olm pic.twitter.com/kCaxXLVEHn
— EFPIA (@EFPIA) June 29, 2020
6. Annemarie Vroom (@AnnemarieVtW)
Annemarie Vroom is a consultant and a PhD in organic chemistry. She is currently a freelance science writer for Science Journalist Biologics & Biosimilars in the Netherlands. She writes about biologics, monoclonal antibodies, and biosimilars. Vroom has contributed towards many scientific, pharmaceutical, and industrial journals in the past.
Twitter followers: 2,892
GlobalData influencer score: 64
7. Lione lreichardt (@LionelREICHARDT)
Lione lreichardt is a healthcare technologist and founder of 7C’s HEALTH by PHARMAGEEK®, a communication and consulting firm. He also blogs on health on PHARMAGEEK®, and is a digital transformation facilitator. Lione also co-founded the pharmaceutical company, Club Digital Pharma, which informs and educates on digital technologies applied to pharmaceutical and related businesses.
Twitter followers: 45,905
GlobalData influencer score: 62
Aujourd'hui pour l'épisode 11 de J'irai tweeter de chez moi j'ai le plaisir et l'honneur de recevoir Laura SPINNEY, journaliste scientifique et romancière. Auteur de "La grande tueuse : comment la grippe espagnole a changé le monde." #JTDCM #E11 @lfspinney https://t.co/TnoG23pCIO pic.twitter.com/bD9fWaTttp
— PHARMAGEEK #hcsmeufr (@LionelREICHARDT) May 27, 2020
8. DIA (@DrugInfoAssn)
The Drug Information Association (DIA) is a global, non-profit association supporting a network of science professionals to address the challenges in the field of life sciences. Formed in 1964, DIA serves as a platform for professionals, peers and patients to discuss and share information on training courses, product development workshops, therapeutic innovation, and more.
Twitter followers: 13,516
GlobalData influencer score: 60
Don't miss our exciting Round Table Discussion on Data Strategy and Privacy Compliance in the Age of Digital Health: GDPR, HIPAA, and CCPA Implications beginning at 12:45PM! #DIA2020
— DIA (@DrugInfoAssn) June 17, 2020
9. Elaine Blais (@eblais2)
Elaine Blais is a patent litigator who specialises in areas such as biosimilars, consumer goods, medtech, pharmaceuticals, and more. She currently serves as partner and head of litigation at the global law firm Goodwin. She is also the founding editor of the Big Molecule Watch blog, and has represented top brands such as Gillette (P&G).
Twitter followers: 700
GlobalData influencer score: 58
Check out this interview my colleague @nikomitroko gave regarding a recently approved biosimilar and what else can be expected in the biosimilars space for the remainder of 2020! @goodwinlaw #GoodwinLaw #biosimilars @centerforbiosimilars https://t.co/27tAAgziqa
— Elaine Blais (@eblais2) June 23, 2020
10. Andrew F Bourgoin (@AndrewFBourgoin)
Andrew F Bourgoin is the director for biosimilar market access strategy and business planning at Boehringer Ingelheim. He is an expert on the US biosimilars market and specialises in marketing, forecasting and competitive intelligence. He has previously worked in various capacities in companies such as Adello Biologics, a biotechnology company, and Thomson Reuters, a news service provider.
Twitter followers: 776
GlobalData influencer score: 52
-1 Oral solids photo for a biosimilar article https://t.co/YMZthfNSRi
— Andrew F Bourgoin (@AndrewFBourgoin) May 26, 2020